Search Medical Condition
Please enter condition
Please choose location from dropdown
 

East Palo Alto, California Clinical Trials

A listing of East Palo Alto, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (1033) clinical trials

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

This Phase II study is designed to evaluate the safety and efficacy of IMCgp100 compared with Investigator's Choice (dacarbazine, ipilimumab or pembrolizumab) in HLA-A*0201 positive adult patients with advanced UM treated in the first line setting with no prior systemic or liver-directed chemo-, radio- or immune-therapy administered in the advanced ...

Phase

0.16 miles

Learn More »

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

The purpose of this study is to determine if an investigational treatment is effective compared with placebo and PVP-Iodine in the treatment of adults and children with adenoviral conjunctivitis.

Phase

0.16 miles

Learn More »

Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus

Up to 275 study eyes with progressive keratoconus will be enrolled. Study eyes will be randomized in a 2:1 ratio to receive CXL treatment or sham/control treatment.The primary efficacy endpoint is a difference of 1 diopter between treatment groups in the mean change in Kmax from baseline to Month 6.

Phase

0.16 miles

Learn More »

Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With Center-involving Diabetic Macular Edema (ciDME)

This is a clinical study where patients with diabetes and a vision threatening eye condition called "Diabetic Macular Edema" receive four injections into the eye at monthly intervals. The patients will already have tried the standard of care without complete success. The patients will be randomized to receive either a ...

Phase

0.16 miles

Learn More »

A Study of AK002 in Patients With Atopic Keratoconjunctivitis Vernal Keratoconjunctivitis and Perennial Allergic Conjunctivitis

This is a Phase 1b, open-label, study to assess the effects of AK002, given as monthly intravenous infusion for 6 doses at up to 3 mg/kg.

Phase

0.16 miles

Learn More »

Tissue Sealant Use in LASIK Enhancement Surgery

Participants will have a comprehensive eye examination once they express an interest in the study. This includes a slit lamp examination of the front of the eye and a dilated fundoscopic examination of the back of the eye. If there is any pathology noted that would exclude the participant from ...

Phase

0.16 miles

Learn More »

A Prospective Contralateral Eye to Eye Comparison of SMILE Surgery to LASIK Surgery

Subjects will have a comprehensive eye examination once they express an interest in the study. This includes a slit lamp examination of the front of the eye and a dilated fundoscopic examination of the back of the eye. If there is any pathology noted that would exclude the subject from ...

Phase

0.16 miles

Learn More »

Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

This is an observational, multicenter study to determine the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early-onset idiopathic bilateral cataracts. Patients who are potentially eligible for study participation will be identified through a chart review of patients who were seen at each study site prior to that ...

Phase N/A

0.16 miles

Learn More »

Study to Assess the Efficacy and Safety of Raxone in LHON Patients

LEROS is an open-label interventional Phase IV study, designed to further assess the efficacy and safety of Raxone in the long-term treatment of LHON patients.

Phase

0.16 miles

Learn More »

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

To assess the safety and tolerability at increasing dose levels of PF-06647020 in patients with advanced solid tumors in order to determine the maximum tolerated dose and select the recommended Phase 2 dose.

Phase

0.16 miles

Learn More »